Bir sonraki

Otomatik oynatma

MRD’s Potential Role in Treating Acute Myeloid Leukemia

0 Görünümler • 07/04/23
Pay
gömmek
administrator
administrator
Aboneler
0

Harry Erba, MD, PhD; Alexander E. Perl, MD; Eunice Wang, MD; and Jorge E. Cortes, MD, debate the current value of minimal residual disease testing for therapeutic decision-making in acute myeloid leukemia and identify the needs to be addressed before use in standard practice.

Daha fazla göster
0 Yorumlar sort Göre sırala
Facebook Yorumları

Bir sonraki

Otomatik oynatma